SARAH SLIVON-VANCHENA: Open Payments
NPI 1568954337 · PLEASANT PRAIRIE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 23 payments from 9 companies in 2025. Trend: 2023 $502 · 2024 $592 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $244 |
| Gilead Sciences, Inc. | 5 | $206 |
| ABBVIE INC. | 3 | $59 |
| Aimmune Therapeutics, Inc. | 2 | $53 |
| Madrigal Pharmaceuticals | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
| Ardelyx, Inc. | 1 | $16 |
Products named: TREMFYA, Livdelzi, ZENPEP, RINVOQ, REZDIFFRA, ENTYVIO, MONOFERRIC, Wegovy.
Industry payments across WI — which companies pay providers there.
